Sponsored Content
Hi-Q Named Finalist at NutraIngredients Asia Awards 2023!
8 Sep 2023Hi-Q has been selected as a finalist at the prestigious NutraIngredients Asia Awards 2023!
Being shortlisted for the Nutrition Research Project Specialty Award highlights the potential impact of Hi-Q's research project. This recognition underscores the importance of further exploration and validation of OliFuco® Oligo Fucoidan as an therapeutic option for cancer cachexia, offering hope for countless individuals affected by this debilitating syndrome.
.png)
Founded in 1998, Hi-Q is a biotech company committed to "Nature Protection and Health Promotion".
Initially focusing on green aquaculture research, our R&D team discovered the vital role of brown seaweed in enhancing fish immune systems. Since 2007, we have been dedicated to researching and developing brown seaweed, resulting in the identification of our brown seaweed extract, OliFuco®, which exhibits unique bi-directional immunomodulation effects with significant benefits in cancer management.
Recognizing the challenges faced in cancer care, especially regarding nutrition resources, we aim to demonstrate the potential of OliFuco® as an adjunctive therapy for cancer patients experiencing cachexia and managing chronic diseases that contribute to cancer risk.
Our cancer-focused research project began in 2008. To date, we have published over 50 scientific papers, with over 30 of these papers directly focusing on its relationship to cancer and the immune system while others related to management of chronic diseases that contribute to cancer risk. These publications provide evidence of the efficacy of Fucoidan in various aspects, including immune modulation, prevention of tumour progression, improvement of chemotherapy and radiotherapy outcomes, improvement of side effects and cancer cachexia.
One significant milestone in our research journey occurred in 2017 when we successfully completed the first double-blind, randomized controlled trial at Kaohsiung Medical University. This landmark trial specifically evaluated the efficacy of OliFuco® as a supplemental therapy in metastatic colorectal cancer patients. The trial conclusively demonstrated the effectiveness of OliFuco® in enhancing the disease control rate among these patients. We are conducting ongoing studies.
Companies mentioned
Related categories
Related news
Rioja Nature Pharma obtains Friend of the Sea certification
1 Apr 2025
Rioja
Nature Pharma takes another step forward in its commitment to excellence and
the environment by obtaining Friend of the Sea certification for its Omega-3
EPA and Omega-3 DHA softgel fish oil food supplement manufacturing lines.
New high-CBD raw material brings opportunities for the nutraceuticals industry
26 Mar 2025
A new high-CBD raw material is available to the nutraceuticals industry. Bedrocan, an experienced cannabis cultivator, explains why non-hemp CBD of consistent content is an advantage.
Read more
Rioja Nature Pharma incorporates Sulphoraphan Smart, an innovative compound patented by Ingredalia, to its catalogue of ingredients.
25 Mar 2025
Sulforaphane is the active ingredient of broccoli that makes this vegetable a superfood, as it activates the cellular defence against inflammation and oxidation. However, its synthesis and absorption is not always correct, as it is degraded before reac...
Read more
Faster, higher, better – Unlock the Power of Mineral Salts in Sports Nutrition
20 Mar 2025
Calcium, Iron, Magnesium, and Zinc fuel athletes' energy and recovery. German manufacturer Dr. Paul Lohmann® provides high-quality Mineral Salts that support peak athletic performance.
Read more
Visit MÜNZING at VITAFOODS 2025 in Barcelona, Spain at booth 5H45
18 Mar 2025
Experience MÜNZING's high-performance MAGRABAR® defoamers at Vitafoods Europe 2025, taking place from 20 to 22 May in Barcelona, Spain. Visit us at booth 5H45 for live demonstrations of our food-grade antifoams and insights into our i...
Read more
FrieslandCampina Ingredients launches Nutri Whey™ ProHeat for the performance and active nutrition market
18 Mar 2025
[18 March 2025] – FrieslandCampina Ingredients, a global leader in proteins and prebiotics, announces the launch of Nutri Whey™ ProHeat – a heat-stable whey protein – to help brands in the performance and active nutrition market...
Read more
Trend alert: photoprotection supplements
18 Mar 2025
The photoprotection market is evolving. More and more consumers are looking for innovative solutions to complement traditional sunscreens, and this is where food supplements with active photoprotective ingredients are making a difference.
Read more
Experts recommended treatment for knee osteoarthritis
17 Mar 2025
Artroveron® Active+ is a complex that helps to repair cartilage and maintain healthy joint so you can continue with daily activities such as walking, climbing stairs, getting out of bed without pain. Artroveron consists of high dose glucosami...
Read more
Protein Powders with Improved Solubility
14 Mar 2025
The clear advantages of fluidized bed technology compared to the drying process of protein powder in the spray tower:- Faster and improved solubility of proteins compared to powders from the spray tower
- Targeted adjustment of the particle size, re...
PharmaLinea's product awarded for innovation in bone and joint health
11 Mar 2025